Compare CRNX & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | BCO |
|---|---|---|
| Founded | 2008 | 1859 |
| Country | United States | United States |
| Employees | N/A | 125 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.2B |
| IPO Year | 2018 | 2009 |
| Metric | CRNX | BCO |
|---|---|---|
| Price | $43.75 | $134.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $75.78 | ★ $163.00 |
| AVG Volume (30 Days) | ★ 897.1K | 217.5K |
| Earning Date | 04-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ 94.12 |
| EPS | N/A | ★ 3.08 |
| Revenue | $1,039,000.00 | ★ $3,562,300,000.00 |
| Revenue This Year | $520.98 | $5.53 |
| Revenue Next Year | $874.13 | $4.97 |
| P/E Ratio | ★ N/A | $42.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.10 | $80.10 |
| 52 Week High | $57.99 | $133.62 |
| Indicator | CRNX | BCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.68 | 67.42 |
| Support Level | $42.80 | $107.92 |
| Resistance Level | $46.05 | N/A |
| Average True Range (ATR) | 2.07 | 3.39 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 25.04 | 99.37 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.